None listed
Conditions
Brief summary
Endoscopic mucosal resection (EMR) has become the primary therapy in the management of large polyps in the colon. It is now the standard of care for safe and effective resection of large (greater than 20mm) non-pedunculated polyps. We aim to perform a comprehensive review of our EMR practice, in particular to determine the safety, efficacy and outcomes, including polyp recurrence at our institution for polyps greater than 20mm undergoing EMR.
Interventions
To perform a comprehensive review of our Endoscopic Submucosal Resection (EMR) practice, in particular to determine the safety, efficacy and outcomes, including polyp recurrence at our institution for polyps greater than 20mm undergoing EMR. The primary outcome will be establishing the proportion of patients who have bleeding and/or perforation. In addition, we wish to define risk factors for both complication and failed/unsuccessful EMR (defined as initial incomplete removal OR recurrence at scheduled surveillance follow-up). Participants will not be required to perform any additional tasks in this study. The total duration of observation for the study will be 1 year post the date of the procedure. All patients in this study will receive usual standard of care practice with EMR - there will be no alteration in practice or data collected.
Sponsors
Eligibility
Inclusion criteria
Consecutive patients undergoing an EMR of a non-pedunculated lesion >20mm.
Exclusion criteria
Incomplete data only